Literature DB >> 2764906

Phospholamban is a good substrate for cyclic GMP-dependent protein kinase in vitro, but not in intact cardiac or smooth muscle.

J P Huggins1, E A Cook, J R Piggott, T J Mattinsley, P J England.   

Abstract

1. Cyclic GMP-dependent protein kinase phosphorylates purified phospholamban. It also phosphorylates phospholamban present in vesicles of cardiac sarcoplasmic reticulum and smooth muscle microsomal fractions, and in transformants of Escherichia coli which contain a plasmid into which a gene encoding phospholamban has been inserted. 2. In vitro the phospholamban present in cardiac sarcoplasmic reticulum membranes is a better substrate for cyclic GMP-dependent protein kinase than for cyclic AMP-dependent protein kinase. 3. Studies using [32P]Pi to label the cellular ATP in intact cardiac or smooth muscle failed to demonstrate that phosphorylation of phospholamban occurs in response to stimuli which increase intracellular cyclic GMP. Possible reasons for this functional separation between increased cyclic GMP and phosphorylation of phospholamban are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2764906      PMCID: PMC1138751          DOI: 10.1042/bj2600829

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  EDRF and cyclic GMP control gating of receptor-operated calcium channels in vascular smooth muscle.

Authors:  T Godfraind
Journal:  Eur J Pharmacol       Date:  1986-07-31       Impact factor: 4.432

2.  Purification and characterization of phospholamban from canine cardiac sarcoplasmic reticulum.

Authors:  L R Jones; H K Simmerman; W W Wilson; F R Gurd; A D Wegener
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

3.  Evidence for a phosphorylation-induced conformational change in phospholamban from the effects of three proteases.

Authors:  J P Huggins; P J England
Journal:  FEBS Lett       Date:  1987-06-08       Impact factor: 4.124

4.  Complete complementary DNA-derived amino acid sequence of canine cardiac phospholamban.

Authors:  J Fujii; A Ueno; K Kitano; S Tanaka; M Kadoma; M Tada
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

5.  Purification and characterization of human H-ras proteins expressed in Escherichia coli.

Authors:  M Gross; R W Sweet; G Sathe; S Yokoyama; O Fasano; M Goldfarb; M Wigler; M Rosenberg
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

6.  The cyclic nucleotide-dependent phosphorylation of aortic smooth muscle membrane proteins.

Authors:  T P Parks; A C Nairn; P Greengard; J D Jamieson
Journal:  Arch Biochem Biophys       Date:  1987-06       Impact factor: 4.013

7.  Cyclic GMP regulation of the plasma membrane (Ca2+-Mg2+)ATPase in vascular smooth muscle.

Authors:  K Furukawa; H Nakamura
Journal:  J Biochem       Date:  1987-01       Impact factor: 3.387

8.  A phospholamban protein phosphatase activity associated with cardiac sarcoplasmic reticulum.

Authors:  E G Kranias; J Di Salvo
Journal:  J Biol Chem       Date:  1986-08-05       Impact factor: 5.157

9.  Evidence for the presence of phospholamban in the endoplasmic reticulum of smooth muscle.

Authors:  L Raeymaekers; L R Jones
Journal:  Biochim Biophys Acta       Date:  1986-06-19

10.  Effects of atrial natriuretic factor, sodium nitroprusside, and acetylcholine on cyclic GMP levels and relaxation in rat aorta.

Authors:  R M Rapoport; S A Waldman; K Schwartz; R J Winquist; F Murad
Journal:  Eur J Pharmacol       Date:  1985-09-24       Impact factor: 4.432

View more
  9 in total

Review 1.  Signal transduction by cGMP in heart.

Authors:  S M Lohmann; R Fischmeister; U Walter
Journal:  Basic Res Cardiol       Date:  1991 Nov-Dec       Impact factor: 17.165

2.  Multisite phosphorylation of the cardiac ryanodine receptor: a random or coordinated event?

Authors:  Jana Gaburjakova; Eva Krejciova; Marta Gaburjakova
Journal:  Pflugers Arch       Date:  2020-10-19       Impact factor: 3.657

Review 3.  Ca2+ pumps in smooth muscle cells.

Authors:  L Raeymaekers; F Wuytack
Journal:  J Muscle Res Cell Motil       Date:  1993-04       Impact factor: 2.698

4.  The expression of canine cardiac phospholamban in heterologous systems.

Authors:  E A Cook; J P Huggins; G Sathe; P J England; J R Piggott
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

Review 5.  Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome.

Authors:  Evangelia G Kranias; Roger J Hajjar
Journal:  Circ Res       Date:  2012-06-08       Impact factor: 17.367

Review 6.  Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases and depolarization.

Authors:  P V Sulakhe; X T Vo
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

7.  Increased effects of C-type natriuretic peptide on contractility and calcium regulation in murine hearts overexpressing cyclic GMP-dependent protein kinase I.

Authors:  Kai C Wollert; Sevdalina Yurukova; Ana Kilic; Frank Begrow; Beate Fiedler; Stepan Gambaryan; Ulrich Walter; Suzanne M Lohmann; Michaela Kuhn
Journal:  Br J Pharmacol       Date:  2003-11-10       Impact factor: 8.739

8.  Disulfide-activated protein kinase G Iα regulates cardiac diastolic relaxation and fine-tunes the Frank-Starling response.

Authors:  Jenna Scotcher; Oleksandra Prysyazhna; Andrii Boguslavskyi; Kornel Kistamas; Natasha Hadgraft; Eva D Martin; Jenny Worthington; Olena Rudyk; Pedro Rodriguez Cutillas; Friederike Cuello; Michael J Shattock; Michael S Marber; Maria R Conte; Adam Greenstein; David J Greensmith; Luigi Venetucci; John F Timms; Philip Eaton
Journal:  Nat Commun       Date:  2016-10-26       Impact factor: 14.919

Review 9.  The role of CaMKII regulation of phospholamban activity in heart disease.

Authors:  Alicia Mattiazzi; Evangelia G Kranias
Journal:  Front Pharmacol       Date:  2014-01-27       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.